Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
"Lysosomal glycogen storage disease with normal acid maltase" which was originally described by Danon et al., is characterized clinically by cardiomyopathy, myopathy and variable mental retardation. The pathological hallmark of the disease is intracytoplasmic vacuoles containing autophagic material and glycogen in skeletal and cardiac muscle cells. Sarcolemmal proteins and basal lamina are associated with the vacuolar membranes. Here we report ten unrelated patients, including one of the patients from the original case report, who have primary deficiencies of LAMP-2, a principal lysosomal membrane protein. From these results and the finding that LAMP-2-deficient mice manifest a similar vacuolar cardioskeletal myopathy, we conclude that primary LAMP-2 deficiency is the cause of Danon disease. To our knowledge this is the first example of human cardiopathy-myopathy that is caused by mutations in a lysosomal structural protein rather than an enzymatic protein.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“| Cardiomyopathies | Whole‐body deletion of Lamp2 | Accelerated development of a vacuolar cardioskeletal myopathy similar to Danon disease | Nishino et al (2000), Tanaka et al (2000) |”
From Autophagy in major human diseases (2021) · cites this paper as Nishino et al (2000)
In the citing paper
“In addition, broad‐spectrum autophagic defects tied to the systemic ablation of LAMP2 (causing Danon disease) account for the early development of hypertrophic cardiomyopathy (Nishino et al, 2000; Tanaka et al, 2000).”
From Autophagy in major human diseases (2021) · cites this paper as Nishino et al, 2000
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
An association between migraine and cutaneous allodynia
Burstein, R., Yarnitsky, D., Goor‐Aryeh, I., Ransil, B. J., & Bajwa, Z. H. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200005)47:5<684::aid-ana27>3.0.co;2-o · Cited by 1,025
Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice
Tanaka, Y., Guhde, G., Suter, A., Eskelinen, E.-L., Hartmann, D., Lüllmann-Rauch, R., Janssen, P. M. L., Blanz, J., von Figura, K., & Saftig, P. (2000) · Nature · doi:10.1038/35022595 · Cited by 925 · cited 1×
“From these results and the finding that LAMP-2-deficient mice manifest a similar vacuolar cardioskeletal myopathy, we conclude that primary LAMP-2 deficiency is the cause of Danon diseas”
ResultA novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis
Town, M., Jean, G., Cherqui, S., Attard, M., Forestier, L., Whitmore, S. A., Callen, D. F., Gribouval, O., Broyer, M., Bates, G. P., et al. (1998) · Nature Genetics · doi:10.1038/ng0498-319 · Cited by 639 · cited 1×
“Our results, together with the recent identification of mutations in the lysosomal proteins cystinosin and sialin that cause nephropathic cystinosi”
ResultLysosomal glycogen storage disease with normal acid maltase
Danon, M. J., Oh, S. J., DiMauro, S., Manaligod, J. R., Eastwood, A., Naidu, S., & Schliselfeld, L. H. (1981) · Neurology · doi:10.1212/wnl.31.1.51 · Cited by 405 · cited 4×
“In 1981, Danon et al.1 reported two boys with the clinical triad of cardiomyopathy, myopathy and mental retardation.”
BackgroundInfluentialSelf-citationSaitoh, O., Wang, W. C., Lotan, R., & Fukuda, M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42823-2 · Cited by 308
A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases
Verheijen, F. W., Verbeek, E., Aula, N., Beerens, C. E. M. T., Havelaar, A. C., Joosse, M., Peltonen, L., Aula, P., Galjaard, H., van der Spek, P. J., et al. (1999) · Nature Genetics · doi:10.1038/70585 · Cited by 293
Lysosomes, a meeting point of proteins, chaperones, and proteases
Cuervo, A. M., & Dice, J. F. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050185 · Cited by 201 · cited 1×
“Alternatively, the unusual muscle pathology in DD might result from impaired lysosomal protein processing because the cytoplasmic tail of LAMP-2 functions as a receptor for the uptake of certain proteins into lysosome in association with the relative molecular mass ( M r ) 73,000 heat shock cognate protei”
BackgroundPattern of malformations in the axial skeleton in human triploid fetuses
Kjær, I., Keeling, J. W., Smith, N. M., & Hansen, B. F. (1997) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19971017)72:2<135::aid-ajmg3>3.0.co;2-u · Cited by 120
Konecki, D. S., Foetisch, K., Zimmer, K.-P., Schlotter, M., & Konecki, U. L. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2528 · Cited by 116 · cited 1×
“Human exon 9 exists in two forms, 9a and 9b, which are alternatively spliced and produce two isoforms, LAMP-2a and LAMP-2b, respectivel”
Background
Research works printed but not linked: 1
- Lewin, B. Genes VI (Oxford Univ. Press, Oxford, 1997).
Cited by
Items 101–200 of 1,000
Law, B. A., Liao, X., Moore, K. S., Southard, A., Roddy, P., Ji, R., Szulc, Z., Bielawska, A., Schulze, P. C., & Cowart, L. A. (2018) · The FASEB Journal · doi:10.1096/fj.201700300r · Cited by 221
Danon Disease: Clinical Features, Evaluation, and Management
D’souza, R. S., Levandowski, C., Slavov, D., Graw, S. L., Allen, L. A., Adler, E., Mestroni, L., & Taylor, M. R. G. (2014) · Circulation: Heart Failure · doi:10.1161/circheartfailure.114.001105 · Cited by 220
“For reasons not yet fully understood, reduction in LAMP2 disrupts intracytoplasmic trafficking and leads to accumulation of autophagic material and often glycogen in skeletal muscle and cardiac muscle cells (Figure 1).(2) Major clinical features include skeletal and cardiac myopathy, cardiac conduction abnormalities,…”
BackgroundPajares, M., Rojo, A. I., Arias, E., Díaz-Carretero, A., Cuervo, A. M., & Cuadrado, A. (2018) · Autophagy · doi:10.1080/15548627.2018.1474992 · Cited by 218
Altered dynamics of the lysosomal receptor for chaperone-mediated autophagy with age
Kiffin, R., Kaushik, S., Zeng, M., Bandyopadhyay, U., Zhang, C., Massey, A. C., Martinez-Vicente, M., & Cuervo, A. M. (2007) · Journal of Cell Science · doi:10.1242/jcs.001073 · Cited by 213
“LAMP-2A is the only isoform shown to participate in CMA (Cuervo and Dice, 1996), whereas mutations in LAMP-2B lead to major impairment in macroautophagy (Nishino et al., 2000).”
BackgroundAMPK and autophagy in glucose/glycogen metabolism
Ha, J., Guan, K.-L., & Kim, J. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.08.002 · Cited by 211
A Mammalian Autophagosome Maturation Mechanism Mediated by TECPR1 and the Atg12-Atg5 Conjugate
Chen, D., Fan, W., Lu, Y., Ding, X., Chen, S., & Zhong, Q. (2012) · Molecular Cell · doi:10.1016/j.molcel.2011.12.036 · Cited by 210
“Autophagic vacuole maturation is defective in certain human diseases including lysosomal storage disease (Cao et al., 2006; Chevrier et al., 2010; Raben et al., 2008) and Danon disease (Nishino et al., 2000).”
Autophagy and Its Normal and Pathogenic States in the Brain
Yamamoto, A., & Yue, Z. (2014) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071013-014149 · Cited by 204
“Although deletion of the LAMP2A isoform has not been reported, a primary defect affecting all LAMP2 isoforms leads to Danon disease, a rare X-linked dominant disorder characterized by myopathy and cardiomyopathy (Danon et al. 1981, Nishino et al. 2000).”
BackgroundSelf-citationde Araujo, M. E. G., Liebscher, G., Hess, M. W., & Huber, L. A. (2020) · Traffic · doi:10.1111/tra.12714 · Cited by 203
Kelekar, A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1363.015 · Cited by 202
Hereditary muscular dystrophies and the heart
Hermans, M. C. E., Pinto, Y. M., Merkies, I. S. J., de Die-Smulders, C. E. M., Crijns, H. J. G. M., & Faber, C. G. (2010) · Neuromuscular Disorders · doi:10.1016/j.nmd.2010.04.008 · Cited by 195
“X-linked vacuolar cardiomyopathy and myopathy (Danon disease) is caused by mutations in the gene encoding lysosomeassociated membrane protein-2 (LAMP-2) at Xq24 [155].”
BackgroundBejarano, E., & Cuervo, A. M. (2010) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200909-102js · Cited by 191
Godar, R. J., Ma, X., Liu, H., Murphy, J. T., Weinheimer, C. J., Kovacs, A., Crosby, S. D., Saftig, P., & Diwan, A. (2015) · Autophagy · doi:10.1080/15548627.2015.1063768 · Cited by 191
“fusion and Danon disease.(27)We examined the effects of partial loss of LAMP2 on autophagy in the myocardium, which is a critical lysosomal pathway stimulated in response to starvation,(11,14,15) and is impaired in mice with complete loss of LAMP2.”
BackgroundResultRecycle or die: The role of autophagy in cardioprotection
Gustafsson, Å. B., & Gottlieb, R. A. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.01.010 · Cited by 188
“Moreover, Danon’s cardiomyopathy is due to a deficiency in the lysosomal protein Lamp-2 which causes a disruption in the autophagosome-lysosome (AtgLys) pathway and accumulation of autophagosomes in the cardiac myocytes [18,31].”
BackgroundTargeting autophagy using metallic nanoparticles: a promising strategy for cancer treatment
Cordani, M., & Somoza, Á. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2973-y · Cited by 188
Matsui, Y., Kyoi, S., Takagi, H., Hsu, C.-P., Hariharan, N., Ago, T., Vatner, S. F., & Sadoshima, J. (2008) · Autophagy · doi:10.4161/auto.5638 · Cited by 187
Asanuma, K., Tanida, I., Shirato, I., Ueno, T., Takahara, H., Nishitani, T., Kominami, E., & Tomino, Y. (2003) · The FASEB Journal · doi:10.1096/fj.02-0580fje · Cited by 186
“Autophagy, a process of bulk protein degradation and organelle turnover, is induced under starvation conditions (2) and has significant relationships with type II (nonapoptotic) programmed cell death (3), neurodegenerative diseases (4), cardiomyopathy (5),”
BackgroundAutophagy in disease: a double-edged sword with therapeutic potential
Martinet, W., Agostinis, P., Vanhoecke, B., Dewaele, M., & de Meyer, G. R. Y. (2009) · Clinical Science · doi:10.1042/cs20080508 · Cited by 186
Bacterial interactions with the autophagic pathway
Dorn, B. R., Dunn, W. A., & Progulske-Fox, A. (2002) · Cellular Microbiology · doi:10.1046/j.1462-5822.2002.00164.x · Cited by 186
“Although autophagy is a highly regulated cellular pathway for the controlled degradation of organelles, uncontrolled autophagy has been implicated in the death of neurons starved of nerve growth factor and in some X-linked myopathies (Xue et al., 1999; Nishino et al., 2000; Chabrol et al., 2001).”
BackgroundAutophagy in Yeast: Mechanistic Insights and Physiological Function
Abeliovich, H., & Klionsky, D. J. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.3.463-479.2001 · Cited by 184
“reported that LAMP-2 deficiency is the cause of X-linked vacuolar cardiomyopathy and myopathy in Danon’s disease (77).”
BackgroundDiscovery of a novel type of autophagy targeting RNA
Fujiwara, Y., Furuta, A., Kikuchi, H., Aizawa, S., Hatanaka, Y., Konya, C., Uchida, K., Yoshimura, A., Tamai, Y., Wada, K., et al. (2013) · Autophagy · doi:10.4161/auto.23002 · Cited by 183
“Lack of LAMP2 causes Danon disease, which is characterized by cardiomyopathy, myopathy and variable mental retardation.(4) LAMP2-deficient mice show increased mortality between 20 and 40 days of age.”
Therapeutic targeting of autophagy in cardiovascular disease
Schiattarella, G. G., & Hill, J. A. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.11.019 · Cited by 180
Misregulation of autophagy and protein degradation systems in myopathies and muscular dystrophies.
Sandri, M., Coletto, L., Grumati, P., & Bonaldo, P. (2013) · Journal of Cell Science · doi:10.1242/jcs.114041 · Cited by 179
“LAMP2 is required for the correct maturation of early autophagic vesicles by their fusion with endosomes and lysosomes.”
BackgroundInfluentialAutophagy in the heart and liver during normal aging and calorie restriction
Wohlgemuth, S. E., Julian, D., Akin, D. E., Fried, J., Toscano, K., Leeuwenburgh, C., & Dunn, Jr. (2007) · Rejuvenation Research · doi:10.1089/rej.2006.0535 · Cited by 179
“…proteins and the extent of autophagic cell death are both attenuated in cardiac hypertrophy, dilated cardiomyopathy and heart failure, 12,14 and dysfunctional autophagy may be important in a number of hereditary diseases (such as Danon disease 15 ) that display cardiomyopathies.”
Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L
Stypmann, J., Gläser, K., Roth, W., Tobin, D. J., Petermann, I., Matthias, R., Mönnig, G., Haverkamp, W., Breithardt, G., Schmahl, W., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092637699 · Cited by 179
Murphy, R. T., Mogensen, J., McGarry, K., Bahl, A., Evans, A., Osman, E., Syrris, P., Gorman, G., Farrell, M., Holton, J. L., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.053 · Cited by 179
Danon Disease as an Underrecognized Cause of Hypertrophic Cardiomyopathy in Children
Yang, Z., McMahon, C. J., Smith, L. R., Bersola, J., Adesina, A. M., Breinholt, J. P., Kearney, D. L., Dreyer, W. J., Denfield, S. W., Price, J. F., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.546481 · Cited by 179
Runx1 prevents wasting, myofibrillar disorganization, and autophagy of skeletal muscle
Wang, X., Blagden, C., Fan, J., Nowak, S. J., Taniuchi, I., Littman, D. R., & Burden, S. J. (2005) · Genes & Development · doi:10.1101/gad.1318305 · Cited by 177
“Moreover, Danon’s disease, which is also typified by the presence of autophagic vacuoles, is caused by mutations in LAMP-2, a lysosomal membrane protein (Nishino et al. 2000; Tanaka et al. 2000).”
BackgroundDysregulation of autophagy as a common mechanism in lysosomal storage diseases
Seranova, E., Connolly, K. J., Zatyka, M., Rosenstock, T. R., Barrett, T., Tuxworth, R. I., & Sarkar, S. (2017) · Essays in Biochemistry · doi:10.1042/ebc20170055 · Cited by 176
Danon disease: a phenotypic expression of LAMP-2 deficiency
Endo, Y., Furuta, A., & Nishino, I. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1385-4 · Cited by 176
“Compared to LAMP-2A, LAMP-2B is more abundantly expressed in the heart, skeletal muscle, and brain at the transcriptional level [19], and the development of Danon disease is largely attributed to LAMP-2B absence [25], as will be discussed later.”
BackgroundSelf-citationBagshaw, R. D., Mahuran, D. J., & Callahan, J. W. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m400128-mcp200 · Cited by 175
“soluble, enzymes is well advanced, only a few defects associated with lysosomal membrane proteins, such as Danon disease (LAMP-2)(1) (8), Niemann-Pick C”
BackgroundRegulated Autophagy Controls Hormone Content in Secretory-Deficient Pancreatic Endocrine β-Cells
Marsh, B. J., Soden, C., Alarcón, C., Wicksteed, B. L., Yaekura, K., Costin, A. J., Morgan, G. P., & Rhodes, C. J. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0077 · Cited by 175
New Insights into the Mechanisms of Macroautophagy in Mammalian Cells
Eskelinen, E. (2008) · International review of cytology · doi:10.1016/s1937-6448(07)66005-5 · Cited by 179
LAMP2A, LAMP2B and LAMP2C: similar structures, divergent roles
Qiao, L., Hu, J., Qiu, X., Wang, C., Peng, J., Zhang, C., Zhang, M., Lu, H., & Chen, W. (2023) · Autophagy · doi:10.1080/15548627.2023.2235196 · Cited by 174
“Although most Danon patients carry mutations that result in deficiency of all three LAMP2 isoforms, some Danon patients carry mutations that only lead to LAMP2B deficiency [83], supporting the notion that LAMP2B deficiency is both necessary and sufficient for Danon pathogenesis [11].”
BackgroundChaperone-assisted degradation: multiple paths to destruction
Kettern, N., Dreiseidler, M., Tawo, R., & Höhfeld, J. (2010) · Biological Chemistry · doi:10.1515/bc.2010.058 · Cited by 174
Autophagy in the cardiovascular system
De Meyer, G. R. Y., & Martinet, W. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.12.011 · Cited by 173
“For instance, severe cardiac dysfunction occurs in patients and mice showing defective autophagic degradation owing to a de fi ciency of the lysosomal-associated membrane protein-2 (LAMP-2) [11,12].”
BackgroundLysosomal LAMP proteins regulate lysosomal pH by direct inhibition of the TMEM175 channel
Zhang, J., Zeng, W., Han, Y., Lee, W.-R., Liou, J., & Jiang, Y. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.06.004 · Cited by 173
Inhibition of Autophagy in Mitotic Animal Cells
Eskelinen, E., Prescott, A. R., Cooper, J., Brachmann, S. M., Wang, L., Tang, X., Backer, J. M., & Lucocq, J. M. (2002) · Traffic · doi:10.1034/j.1600-0854.2002.31204.x · Cited by 172
“Other studies in Lamp2-deficient mice have also highlighted defective autophagy as a possible cause of cardiomyopathy and myopathy of Danon disease (4, 5).”
BackgroundDanon’s disease as a cause of hypertrophic cardiomyopathy: a systematic survey
Charron, P., Villard, E., Sébillon, P., Laforêt, P., Maisonobe, T., Duboscq-Bidot, L., Romero, N., Drouin-Garraud, V, Frébourg, T., Richard, P., et al. (2004) · Heart · doi:10.1136/hrt.2003.029504 · Cited by 172
Palikaras, K., Daskalaki, I., Markaki, M., & Tavernarakis, N. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.04.005 · Cited by 171
“Defective autophagy inmyocytes results in alteredmitochondrialmorphology, accrual of dysfunctional mitochondria contributing to disorganized sarcomeres, contractile impairment and eventually to heart failure (Jaber & Zong, 2013; Nakai et al., 2007; Nishino et al., 2000; Tanaka et al., 2000).”
BackgroundLAMP1/CD107a is required for efficient perforin delivery to lytic granules and NK-cell cytotoxicity
Krzewski, K., Gil-Krzewska, A., Nguyen, V., Peruzzi, G., & Coligan, J. E. (2013) · Blood · doi:10.1182/blood-2012-08-453738 · Cited by 170
“In humans, mutations in LAMP2 cause Danon disease, believed to arise from aberrant autophagy.(20) LAMP2-deficient mice also accumulate autophagic vacuoles in several tissues.”
BackgroundZhang, X., Wang, Q., Wang, X., Chen, X., Shao, M., Zhang, Q., Guo, D., Wu, Y., Li, C., Wang, W., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108599 · Cited by 170
Brain Disorders Due to Lysosomal Dysfunction
Fraldi, A., Klein, A. D., Medina, D. L., & Settembre, C. (2016) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-070815-014031 · Cited by 170
Solomon, M. A., & Muro, S. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.004 · Cited by 170
“proteins Lysosomal integrity disturbed Danon disease [38]”
Mitochondrial dynamics and cell death in heart failure
Marín-García, J., & Akhmedov, A. T. (2016) · Heart Failure Reviews · doi:10.1007/s10741-016-9530-2 · Cited by 169
Proteasomal and lysosomal protein degradation and heart disease
Wang, X., & Robbins, J. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.11.006 · Cited by 168
“For example, primary deficiency of LAMP-2, an essential lysosomal membrane protein, results in vacuolar cardiomyopathy and myopathy (Danon disease) in humans and mice deficient of LAMP-2 develop a similar phenotype [91].”
Hydroxychloroquine-Induced Cardiomyopathy: Case Report, Pathophysiology, Diagnosis, and Treatment
Yogasundaram, H., Putko, B. N., Tien, J., Paterson, D. I., C̆ujec, B., Ringrose, J., & Oudit, G. Y. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.08.016 · Cited by 166
Lysosomal myopathies: An excessive build-up in autophagosomes is too much to handle
Malicdan, M. C. V., Noguchi, S., Nonaka, I., Säftig, P., & Nishino, I. (2008) · Neuromuscular Disorders · doi:10.1016/j.nmd.2008.04.010 · Cited by 168
“However, Danon disease is not a glycogen storage disease as the disease is caused by the primary deficiency of a lysosomal membrane protein, lysosome-associated membrane protein-2 (LAMP-2), instead of a glycolytic enzyme [15].”
BackgroundSelf-citationTherapeutic Targeting of Autophagy: Potential and Concerns in Treating Cardiovascular Disease
Orogo, A. M., & Gustafsson, Å. B. (2015) · Circulation Research · doi:10.1161/circresaha.116.303791 · Cited by 166
“Defects in the autophagy process lead to development of heart failure.(2,3) Autophagy is also an adaptive response to ensure survival of myocytes during unfavorable conditions.”
BackgroundUntangling Autophagy Measurements: All Fluxed Up
Gottlieb, R. A., Andres, A. M., Sin, J., & Taylor, D. P. J. (2015) · Circulation Research · doi:10.1161/circresaha.116.303787 · Cited by 165
OHMURAYA, M., HIROTA, M., ARAKI, M., MIZUSHIMA, N., MATSUI, M., MIZUMOTO, T., HARUNA, K., KUME, S., TAKEYA, M., & OGAWA, M. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.057 · Cited by 165
Issa, A.-R., Sun, J., Petitgas, C., Mesquita, A., Dulac, A., Robin, M., Mollereau, B., Jenny, A., Chérif-Zahar, B., & Birman, S. (2018) · Autophagy · doi:10.1080/15548627.2018.1491489 · Cited by 152
“In humans, LAMP2 gene deficiency leads to Danon disease, histologically characterized by an extensive accumulation of autophagic vacuoles in various tissues and defects in autophagosome-lysosome fusion [21,89,90].”
BackgroundAutophagy in cardiovascular disease
Martinet, W., Knaapen, M., Kockx, M. M., & Meyer, G. R. Y. D. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.08.004 · Cited by 162
Lysosomal quality control of cell fate: a novel therapeutic target for human diseases
Zhu, S., Yao, R.-Q., Li, Y., Zhao, P., Ren, C., Du, X., & Yao, Y.-M. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03032-5 · Cited by 161
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, J., Abeliovich, H., Acevedo‐Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Parasites & Vectors · doi:10.5167/uzh-131237 · Cited by 169
Constitutive autophagy: vital role in clearance of unfavorable proteins in neurons
Komatsu, M., Ueno, T., Waguri, S., Uchiyama, Y., Kominami, E., & Tanaka, K. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402120 · Cited by 160
GRASP55 Senses Glucose Deprivation through O-GlcNAcylation to Promote Autophagosome-Lysosome Fusion
Zhang, X., Wang, L., Lak, B., Li, J., Jokitalo, E., & Wang, Y. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.03.023 · Cited by 160
VMA21 deficiency prevents vacuolar ATPase assembly and causes autophagic vacuolar myopathy
Ramachandran, N., Munteanu, I., Wang, P., Ruggieri, A., Rilstone, J. J., Israelian, N., Naranian, T., Paroutis, P., Guo, R., Ren, Z.-P., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-012-1073-6 · Cited by 157
“Apart from chloroquine myopathy, the differential diagnosis of XMEA includes Danon disease, which results from LAMP2 deficiency [24].”
BackgroundSelf-citationEPG5 -related Vici syndrome: a paradigm of neurodevelopmental disorders with defective autophagy
Byrne, S., Jansen, L., U-King-Im, J.-M., Siddiqui, A., Lidov, H. G. W., Bodi, I., Smith, L., Mein, R., Cullup, T., Dionisi-Vici, C., et al. (2016) · Brain · doi:10.1093/brain/awv393 · Cited by 142
“The defects implicated in Danon disease (Nishino et al., 2000) and X-linked myopathy with excessive autophagy (MEAX) (Ramachandran et al.”
BackgroundLysosomal storage disorders: the need for better pediatric recognition and comprehensive care
Wilcox, W. R. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.01.049 · Cited by 156
Liver injury in α1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury
Perlmutter, D. H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216787 · Cited by 158
Chaperone‐mediated autophagy in health and disease
Kon, M., & Cuervo, A. M. (2010) · FEBS Letters · doi:10.1016/j.febslet.2009.12.025 · Cited by 135
“Changes in CMA are also likely to occur in Danon disease, a lysosomal glycogen storage disorder with normal acid maltase activity, recently linked to mutation in the lamp2 gene [36].”
BackgroundMolecular and cellular basis of lysosomal transmembrane protein dysfunction
Ruivo, R., Anne, C., Sagné, C., & Gasnier, B. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.12.008 · Cited by 157
“Danon disease 300257 X-linked dominant LAMP2, Xq24 [141] LAMP2 (LAMPB,”
BackgroundInfluentialRole of the Apg12 conjugation system in mammalian autophagy
Mizushima, N., Yoshimori, T., & Ohsumi, Y. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00343-6 · Cited by 159
Endo‐lysosomal and autophagic dysfunction: a driving factor in Alzheimer's disease?
Whyte, L. S., Lau, A. A., Hemsley, K. M., Hopwood, J. J., & Sargeant, T. J. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13935 · Cited by 150
Liver injury in α1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury
Perlmutter, D. H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16787 · Cited by 150
Unifying Nomenclature for the Isoforms of the Lysosomal Membrane Protein LAMP‐2
Eskelinen, E., Cuervo, A. M., Taylor, M. R. G., Nishino, I., Blum, J. S., Dice, J. F., Sandoval, I. V., Lippincott‐Schwartz, J., August, J. T., & Saftig, P. (2005) · Traffic · doi:10.1111/j.1600-0854.2005.00337.x · Cited by 128
Self-citationTowbin, J. A., & Jefferies, J. L. (2017) · Circulation Research · doi:10.1161/circresaha.117.310987 · Cited by 149
“The underlying abnormality affects lysosomal function and is because of mutations in the LAMP2.(124,125) The”
BackgroundTimosaponin A-III Induces Autophagy Preceding Mitochondria-Mediated Apoptosis in HeLa Cancer Cells
Sy, L.-K., Yan, S.-C., Lok, C.-N., Man, R. Y. K., & Che, C.-M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1983 · Cited by 141
Exercise reestablishes autophagic flux and mitochondrial quality control in heart failure
Campos, J. C., Queliconi, B. B., Bozi, L. H. M., Bechara, L. R. G., Dourado, P. M. M., Andres, A. M., Jannig, P. R., Gomes, K. M. S., Zambelli, V. O., Rocha-Resende, C., et al. (2017) · Autophagy · doi:10.1080/15548627.2017.1325062 · Cited by 146
“Either LAMP2 or CTSL deficiency causes impaired autophagic flux and cardiomyopathy in rodents and humans.(29,30,36,37) Of interest, we found an increased cardiac CTSL activity in heart failure animals compared with shamtreated, suggesting a compensatory mechanism due to impaired autophagic flux.”
BackgroundShires, S. E., & Gustafsson, Å. B. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1254-6 · Cited by 133
“In addition, the lysosomal-associated membrane protein 2 (LAMP-2) is required for the fusion between autophagosomes and lysosomes, and LAMP-2 deficiency causes accumulation of autophagosomes in myocytes, which leads to a lethal cardiomyopathy [20, 21].”
LAMP-2B regulates human cardiomyocyte function by mediating autophagosome–lysosome fusion
Chi, C., Leonard, A., Knight, W. E., Beussman, K. M., Zhao, Y., Cao, Y., Londono, P., Aune, E., Trembley, M. A., Small, E. M., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1808618116 · Cited by 145
“Autophagic dysregulation has been described in muscle tissues and hiPSC-CMs derived from patients with Danon disease (9, 12, 13).”
BackgroundResultValapala, M., Wilson, C., Hose, S., Bhutto, I. A., Grebe, R., Dong, A., Greenbaum, S., Gu, L., Sengupta, S., Cano, M., et al. (2014) · Autophagy · doi:10.4161/auto.27292 · Cited by 144
Nishino, I. (2006) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2006.06.004 · Cited by 144
Self-citationJu, J. S., & Weihl, C. C. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq157 · Cited by 143
Aki, T., Yamaguchi, K., Fujimiya, T., & Mizukami, Y. (2003) · Oncogene · doi:10.1038/sj.onc.1207197 · Cited by 144
“…that either mutation in – or knock out of – the lysosome-associated membrane protein-2 (LAMP-2) gene causes lysosomal dysfunction and subsequent cardiomyopathy with autophagic vacuoles, in which autophagic protein degradations are severely impaired (Nishino et al., 2000; Tanaka et al., 2000).”
BackgroundGu, S., Tan, J., Li, Q., Liu, S., Ma, J., Zheng, Y., Liu, J., Bi, W., Sha, P., Li, X., et al. (2020) · Circulation Research · doi:10.1161/circresaha.119.316388 · Cited by 142
Uddin, M. S., Mamun, A. A., Labu, Z. K., Hidalgo‐Lanussa, O., Barreto, G. E., & Ashraf, G. M. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27588 · Cited by 141
“In muscle, as well as heart cells, autophagy appears to have an extraordinary maintenance part in the turnover of cytoplasmic components as well as mitochondria (Kuma et al., 2004; Nishino, 2003; Nishino et al., 2000; Tanaka et al., 2000).”
BackgroundThe beneficial role of proteolysis in skeletal muscle growth and stress adaptation
Bell, R. A. V., Al-Khalaf, M., & Megeney, L. A. (2016) · Skeletal Muscle · doi:10.1186/s13395-016-0086-6 · Cited by 119
“For instance, in patients with Danon disease, glycogen granules accumulate in autophagosomes that are unable to fuse with lysosomes for proper clearance, which leads to muscle weakness [82].”
BackgroundEmerging connections between RNA and autophagy
Frankel, L. B., Lubas, M., & Lund, A. H. (2017) · Autophagy · doi:10.1080/15548627.2016.1222992 · Cited by 135
Bögershausen, N., Shahrzad, N., Chong, J. X., von Kleist-Retzow, J., Stanga, D., Li, Y., Bernier, F. P., Loucks, C. M., Wirth, R., Puffenberger, E. G., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.05.028 · Cited by 134
Dual Role of Autophagy in Diseases of the Central Nervous System
Bar-Yosef, T., Damri, O., & Agam, G. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00196 · Cited by 125
“…amyloid-precursor protein (APP) proteolysis (Yu et al., 2005; Martinet et al., 2009) with an unclear biological function (Nixon, 2007); (ii) neurofibrillary tangles composed mainly of tau-proteins that are abnormally phosphorylated and aggregated into filaments inside the neurons (Nixon, 2007).”
WINCHESTER, B. G. (2001) · European Journal of Paediatric Neurology · doi:10.1053/ejpn.2000.0428 · Cited by 134
Lysosomal proteins in cell death and autophagy
Mrschtik, M., & Ryan, K. M. (2015) · The FEBS Journal · doi:10.1111/febs.13253 · Cited by 121
Wilke, S., Krausze, J., & Büssow, K. (2012) · BMC Biology · doi:10.1186/1741-7007-10-62 · Cited by 130
“Surviving mice have a phenotype that corresponds to Danon disease, a rare genetic condition caused by LAMP-2 deficiency [19].”
BackgroundAutophagic vacuolar myopathies
Nishino, I. (2003) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-003-0040-y · Cited by 130
Self-citationAutophagy during cardiac remodeling
Nishida, K., & Otsu, K. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.12.003 · Cited by 131
Autophagy in T‐cell development, activation and differentiation
Bronietzki, A. W., Schuster, M., & Schmitz, I. (2015) · Immunology & Cell Biology · doi:10.1038/icb.2014.81 · Cited by 121
AMPK: a therapeutic target of heart failure—not only metabolism regulation
Li, X., Liu, J., Lü, Q., Ren, D., Sun, X., Rousselle, T. V., Tan, Y., & Li, J. (2019) · Bioscience Reports · doi:10.1042/bsr20181767 · Cited by 128
Disease model: LAMP-2 enlightens Danon disease
Säftig, P., FIGURA, K. V., Tanaka, Y., & Lüllmann‐Rauch, R. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(00)01868-2 · Cited by 130
Gamp, A.-C. (2003) · Human Molecular Genetics · doi:10.1093/hmg/12.6.631 · Cited by 127
“Whereas the deficiency of the more abundant lysosomal membrane protein LAMP-1 (24) causes no overt phenotype in mice, the lack of LAMP-2 (25) causes a characteristic phenotype with cardiomyopathy and myopathy resembling human patients with Danon Disease (26,27).”
BackgroundKanamori, H., Takemura, G., Maruyama, R., Goto, K., Tsujimoto, A., Ogino, A., Li, L., Kawamura, I., Takeyama, T., Kawaguchi, T., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080875 · Cited by 128
Miyata, S., Takemura, G., Kawase, Y., Li, Y., Okada, H., Maruyama, R., Ushikoshi, H., Esaki, M., Kanamori, H., Li, L., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050137 · Cited by 128
“(Am J Pathol 2006, 168:386–397; DOI: 10.2353/ajpath.2006.050137) Autophagy was originally defined as the process of sequestration of intracellular components and their subsequent degradation by lysosomal vacuoles.1 Although autophagy is ongoing as a normal process, abnormal autophagy can cause various neuromuscular de…”
BackgroundInfluentialDefects of Vps15 in skeletal muscles lead to autophagic vacuolar myopathy and lysosomal disease
Nemazanyy, I., Blaauw, B., Paolini, C., Caillaud, C., Protasi, F., Mueller, A., Proikas‐Cezanne, T., Russell, R. C., Guan, K., Nishino, I., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202057 · Cited by 126
Self-citationNascimento, R. M. P., Otto, P. A., de Brouwer, A. P. M., & Vianna‐Morgante, A. M. (2006) · The American Journal of Human Genetics · doi:10.1086/507047 · Cited by 126
Autophagy Mechanism, Regulation, Functions, and Disorders
Badadani, M. (2012) · ISRN Cell Biology · doi:10.5402/2012/927064 · Cited by 124
DiMauro, S., & Lamperti, C. (2001) · Muscle & Nerve · doi:10.1002/mus.1103 · Cited by 124
“Immunohistochemical studies in some patients had shown that the membrane of the vacuoles stained positively for several sarcolemmal proteins, suggesting that the vacuoles may originate from abnormal infolding of the sarcolemma.99 Last year, Nishino et al.101 identified different pathogenic mutations in a gene on the X…”
BackgroundSelf-citationDeneubourg, C., Ramm, M., Smith, L. J., Baron, O., Singh, K., Byrne, S., Duchen, M. R., Gautel, M., Eskelinen, E., Fanto, M., et al. (2021) · Autophagy · doi:10.1080/15548627.2021.1943177 · Cited by 120
“the complex neuronal environment represents the ultimate goal [174].”
BackgroundInfluentialEpidemiology of lysosomal storage diseases: an overview
Fuller, M., Meikle, P. J., & Hopwood, J. J. (2006) · Europe PMC (PubMed Central) · Cited by 120
Vasile, V. C., Ommen, S. R., Edwards, W. D., & Ackerman, M. J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.151 · Cited by 120
Developmentally regulated trafficking of the lysosomal membrane protein p67 in Trypanosoma brucei
Alexander, D. L., Schwartz, K. J., Balber, A. E., & Bangs, J. D. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.16.3253 · Cited by 121
Metadata
- Authors
- Nishino, I., Fu, J., Tanji, K., Yamada, T., Shimojo, S., Koori, T., Mora, M., Riggs, J. E., Oh, S. J., Koga, Y., Sue, C. M., Yamamoto, A., Murakami, N., Shanske, S., Byrne, E., Bonilla, E., Nonaka, I., DiMauro, S., & Hirano, M.
- Affiliations
- Columbia University (US)
- Kyushu University (JP)
- St. Marianna University School of Medicine (JP)
- Yokohama Rosai Hospital (JP)
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- West Virginia University (US)
- University of Alabama at Birmingham (US)
- Kurume University (JP)
- National Center of Neurology and Psychiatry (JP)
- St Vincent's Hospital Melbourne (AU)
- Corresponding author
- Nishino, Ichizo
- ORCID
- Venue
- Nature
- Published
- 2000-08
- Volume
- 406
- Issue
- 6798
- Pages
- 906-910
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2109716633
- Cited by
- 959
- References
- 28
- Citations by year
- 2026: 24 · 2025: 31 · 2024: 30 · 2023: 44 · 2022: 35 · 2021: 44 · 2020: 45 · 2019: 46 · 2018: 57 · 2017: 45 · 2016: 62 · 2015: 44 · 2014: 40 · 2013: 51 · 2012: 45
- FWCI
- 14.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- Danon disease, lysosomal membrane proteins, lysosomal storage disease, cardiomyopathy, myopathy, intracytoplasmic vacuoles, glycogen storage disease
- MeSH terms
- DNA Mutational Analysis, Female, Humans, Immunohistochemistry, Genetic Linkage, Male, Membrane Glycoproteins, Molecular Sequence Data, Muscular Diseases, Cardiomyopathies, Vacuoles, X Chromosome, Blotting, Western, Antigens, CD, Lysosomal Storage Diseases, Sequence Analysis, DNA, Muscle, Skeletal, Lysosomal Membrane Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.